Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function Academic Article uri icon


MeSH Major

  • Antineoplastic Agents
  • Melphalan
  • Retinal Neoplasms
  • Retinoblastoma


  • Minimal baseline ERGs do not preclude significant recovery of retinal function after OAC. Good correlation exists between ERG outcomes at 3 months and those at subsequent follow-ups, suggesting that ERG amplitudes at 3-month post-OAC can prognosticate longer term retinal function, and that improvement is durable. For eyes presenting with RD, RD resolution is necessary but not sufficient for significant (≥25 μV) increases in ERG amplitudes.

publication date

  • August 18, 2016



  • Academic Article



  • eng

PubMed Central ID

  • PMC5637273

Digital Object Identifier (DOI)

  • 10.1136/bjophthalmol-2016-308591

PubMed ID

  • 27539090

Additional Document Info